Market Overview

Twist Bioscience: Q4 Earnings Insights



Shares of Twist Bioscience (NASDAQ:TWST) were unchanged after the company reported Q4 results.

Quarterly Results

Earnings per share increased 43.75% year over year to ($0.54), which beat the estimate of ($0.70).

Revenue of $32,432,000 rose by 106.10% year over year, which beat the estimate of $22,670,000.


Twist Bioscience hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Nov 23, 2020

Time: 08:00 AM

ET Webcast URL:

Price Action

Company's 52-week high was at $117.69

Company's 52-week low was at $18.52

Price action over last quarter: Up 87.41%

Company Description

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead.


Related Articles (TWST)

View Comments and Join the Discussion!

Posted-In: Earnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at